Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

From what we can see, insiders were net buyers in Harvard Bioscience, Inc.'s (NASDAQ:HBIO ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

These bank stocks are all $50 billion or more in market value with a 3% yield or higher.